A Mild Synthesis of Aryl Triflates Enabling the Late‐Stage Modification of Drug Analogs and Complex Peptides
Chemistry – A European Journal · 2023
DOI: 10.1002/chem.202301421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2023. Verfasst von Stefan Schiesser und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Pepparedsle…. Hauptthemen laut MEDLINE: Phenols, Peptides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We report the discovery of a straightforward protocol to convert phenols into the corresponding aryl triflates using 1‐methyl‐3‐((trifluoromethyl)sulfonyl)‐1,3‐dihydro‐2 H ‐benzo[ d ]imidazol‐2‐one in the presence of a fluoride source. This novel reagent can be handled without any precautions to exclude air or moisture making this method highly convenient. The reactions generally show very clean conversions within only a few minutes at room temperature. The mild conditions allow the so far unprecedented O ‐triflation of tyrosine in peptides bearing challenging side chains present for example in arginine and histidine including the late‐stage triflation of complex bioactive peptides. We show how aryl triflates – an interesting but so far underutilized group – can be used to optimize physicochemical and in vitro properties of compound series in medicinal chemistry. We believe that this method is highly attractive for applications in peptide functionalization as well as automated and medicinal chemistry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.
- Department of Chemistry and Molecular Biology, Göteborgs universitet, Kemigården 4, 41296, Gothenburg, Sweden.
- Current address: Early Chemical Development, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.
- École européenne de chimie, polymères et matériaux de Strasbourg, Université de Strasbourg, 25 Rue Becquerel, 67200, Strasbourg, France.
- Early Product Development and Manufacturing, Pharmaceutical Sciences R&D, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.
Zitieren
APA
Schiesser, S., Ceklarz, J., Kollback, J., Borowiec, L., Fagerlund, J., Vahdat, S., Lindhagen, M., & Dwichandra Putra, O. (2023). A Mild Synthesis of Aryl Triflates Enabling the Late‐Stage Modification of Drug Analogs and Complex Peptides. Chemistry – A European Journal. https://doi.org/10.1002/chem.202301421
Vancouver
Schiesser S, Ceklarz J, Kollback J, Borowiec L, Fagerlund J, Vahdat S, et al. A Mild Synthesis of Aryl Triflates Enabling the Late‐Stage Modification of Drug Analogs and Complex Peptides. Chemistry – A European Journal. 2023. doi:10.1002/chem.202301421
BibTeX
@article{Schiesser2023,
author = {Schiesser, Stefan and Ceklarz, Joanna and Kollback, Johanna and Borowiec, Lucie and Fagerlund, Julia and Vahdat, Shakiba and Lindhagen, Marika and Dwichandra Putra, Okky},
title = {A Mild Synthesis of Aryl Triflates Enabling the Late‐Stage Modification of Drug Analogs and Complex Peptides},
journal = {Chemistry – A European Journal},
year = {2023},
doi = {10.1002/chem.202301421}
}
EUVIMED